Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

9.10
Delayed Data
As of May 02
 +0.04 / +0.44%
Today’s Change
6.17
Today|||52-Week Range
22.66
-26.55%
Year-to-Date

Today’s Trading

Previous close9.06
Today’s open9.10
Day’s range8.70 - 9.20
Volume55,517
Average volume (3 months)149,576
Market cap$266.6M
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-12.28%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc-0.13-1.52%
ADXSAdvaxis Inc+0.06+0.78%
SRNESorrento Therapeutic...+0.12+1.75%
ABUSArbutus Biopharma Co...-0.13-2.63%
Data as of 3:59pm ET, 05/02/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs